» Articles » PMID: 23897595

Translational Paradigms in Scientific and Clinical Imaging of Cardiac Development

Overview
Date 2013 Jul 31
PMID 23897595
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital heart defects (CHD) are the most prevalent congenital disease, with 45% of deaths resulting from a congenital defect due to a cardiac malformation. Clinically significant CHD permit survival upon birth, but may become immediately life threatening. Advances in surgical intervention have significantly reduced perinatal mortality, but the outcome for many malformations is bleak. Furthermore, patients living while tolerating a CHD often acquire additional complications due to the long-term systemic blood flow changes caused by even subtle anatomical abnormalities. Accurate diagnosis of defects during fetal development is critical for interventional planning and improving patient outcomes. Advances in quantitative, multidimensional imaging are necessary to uncover the basic scientific and clinically relevant morphogenetic changes and associated hemodynamic consequences influencing normal and abnormal heart development. Ultrasound is the most widely used clinical imaging technology for assessing fetal cardiac development. Ultrasound-based fetal assessment modalities include motion mode (M-mode), two dimensional (2D), and 3D/4D imaging. These datasets can be combined with computational fluid dynamics analysis to yield quantitative, volumetric, and physiological data. Additional imaging modalities, however, are available to study basic mechanisms of cardiogenesis, including optical coherence tomography, microcomputed tomography, and magnetic resonance imaging. Each imaging technology has its advantages and disadvantages regarding resolution, depth of penetration, soft tissue contrast considerations, and cost. In this review, we analyze the current clinical and scientific imaging technologies, research studies utilizing them, and appropriate animal models reflecting clinically relevant cardiogenesis and cardiac malformations. We conclude with discussing the translational impact and future opportunities for cardiovascular development imaging research.

Citing Articles

Comparative analysis of metallic nanoparticles as exogenous soft tissue contrast for live in vivo micro-computed tomography imaging of avian embryonic morphogenesis.

Gregg C, Butcher J Dev Dyn. 2016; 245(10):1001-10.

PMID: 27447729 PMC: 5026601. DOI: 10.1002/dvdy.24433.


Respiratory Effects on Fontan Circulation During Rest and Exercise Using Real-Time Cardiac Magnetic Resonance Imaging.

Wei Z, Whitehead K, Khiabani R, Tree M, Tang E, Paridon S Ann Thorac Surg. 2016; 101(5):1818-25.

PMID: 26872728 PMC: 4842151. DOI: 10.1016/j.athoracsur.2015.11.011.

References
1.
Dimopoulos K, Diller G, Petraco R, Koltsida E, Giannakoulas G, Tay E . Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease. Eur Heart J. 2009; 31(5):595-601. DOI: 10.1093/eurheartj/ehp495. View

2.
McElhinney D, Marshall A, Wilkins-Haug L, Brown D, Benson C, Silva V . Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation. 2009; 120(15):1482-90. PMC: 4235336. DOI: 10.1161/CIRCULATIONAHA.109.848994. View

3.
Dhenain M, Ruffins S, Jacobs R . Three-dimensional digital mouse atlas using high-resolution MRI. Dev Biol. 2001; 232(2):458-70. DOI: 10.1006/dbio.2001.0189. View

4.
Roest A, de Roos A . Imaging of patients with congenital heart disease. Nat Rev Cardiol. 2011; 9(2):101-15. DOI: 10.1038/nrcardio.2011.162. View

5.
Kleinman C, Hobbins J, Jaffe C, Lynch D, TALNER N . Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics. 1980; 65(6):1059-67. View